The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use.
Boxes of the Johnson & Johnson COVID-19 vaccine are seen at the McKesson Corporation, amid the coronavirus disease outbreak, in Shepherdsville, U.S., March 1, 2021. Timothy D. Easley/Pool via REUTERS/File Photomust throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use.
Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated.plant for manufacturing the J&J vaccine. Production of J&J's vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant.
Safety concerns about the J&J vaccine paired with flagging U.S. demand for vaccinations in general have slowed rollout of the one-shot vaccine to a crawl. Close to half of the 21 million doses produced for the United States sit unused.The FDA said its decision allows for the J&J doses to be used in the United States or exported.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA tells Johnson & Johnson to toss 60 million Covid vaccine dosesThe FDA has told Johnson & Johnson to discard about 60,000,000 doses of its Covid-19 vaccine that were produced at a troubled plant in Baltimore, according to 2 people familiar with the matter.
Read more »
Johnson & Johnson says FDA has extended shelf life of single-dose COVID vaccine by six weeksOriginal three-month expiration dates loomed at end of June.
Read more »
Moderna Asks FDA For Emergency Approval Of Its Covid-19 Vaccine In Teens Aged 12-17Moderna announced that it has filed a request with the FDA for Emergency Use Authorization of its Covid-19 vaccine in teens aged 12-17
Read more »
Moderna seeks FDA authorization for Covid-19 vaccine for people ages 12 to 17Moderna has filed with the US Food and Drug Administration for emergency use authorization for its Covid-19 vaccine for people ages 12 to 17, according to a news release from the company.
Read more »
Moderna’s Covid-19 Vaccine Seeks FDA Authorization for Use in AdolescentsModerna asked the FDA to authorize expanding the use of its Covid-19 vaccine to people as young as 12. The application means Moderna’s shot could be cleared for use in the older children this summer.
Read more »
Biden and Johnson expected to commit to lifting US-UK Covid-19 travel restrictionsCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Read more »